Pretransplant Pulmonary Function Predicts Cytomegalovirus-Associated Interstitial Pneumonia following Bone Marrow Transplantation
- 1 November 1992
- Vol. 102 (5) , 1484-1490
- https://doi.org/10.1378/chest.102.5.1484
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- A Randomized, Controlled Trial of Prophylactic Ganciclovir for Cytomegalovirus Pulmonary Infection in Recipients of Allogeneic Bone Marrow TransplantsNew England Journal of Medicine, 1991
- GANCICLOVIR/IMMUNOGLOBULIN COMBINATION THERAPY FOR THE TREATMENT OF HUMAN CYTOMEGALOVIRUS-ASSOCIATED INTERSTITIAL PNEUMONIA IN BONE MARROW ALLOGRAFT RECIPIENTSTransplantation, 1988
- Treatment of Cytomegalovirus Pneumonia with Ganciclovir and Intravenous Cytomegalovirus Immunoglobulin in Patients with Bone Marrow TransplantsAnnals of Internal Medicine, 1988
- Pulmonary function after bone marrow transplantation for chronic myeloid leukaemia.Thorax, 1988
- Lung function changes after allogenic bone marrow transplantation.Thorax, 1986
- Risk Factors for Cytomegalovirus Infection after Human Marrow TransplantationThe Journal of Infectious Diseases, 1986
- Pulmonary Complications of Bone Marrow TransplantationChest, 1985
- Reduced lung function in leukaemia patients undergoing bone marrow transplantationScandinavian Journal of Haematology, 1984
- Pulmonary function in patients undergoing bone marrow transplantationMedical and Pediatric Oncology, 1984
- Nonbacterial Pneumonia After Allogeneic Marrow Transplantation: A Review of Ten Years' ExperienceClinical Infectious Diseases, 1982